0001213900-22-040288.txt : 20220719 0001213900-22-040288.hdr.sgml : 20220719 20220719160650 ACCESSION NUMBER: 0001213900-22-040288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220716 FILED AS OF DATE: 20220719 DATE AS OF CHANGE: 20220719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fry Hannah CENTRAL INDEX KEY: 0001938146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 221091637 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 204580525 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ArTara Therapeutics, Inc. DATE OF NAME CHANGE: 20200110 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 4 1 ownership.xml X0306 4 2022-07-16 0 0001359931 Protara Therapeutics, Inc. TARA 0001938146 Fry Hannah C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR NEW YORK NY 10010 0 1 0 0 VP, Controller Common Stock 2022-07-16 4 A 0 25000 0.00 A 27600 D The shares being reported are being issued pursuant to a restricted stock unit (RSU) award, of which each RSU represents a contingent right to receive one share of Issuer's common stock. The RSUs vest one hundred percent (100%) on the first anniversary of July 16, 2022. /s/ Mary Grendell, Attorney-in-Fact 2022-07-18